Cryptosporidiosis 

  • Author: Miguel M Cabada, MD; Chief Editor: Burke A Cunha, MD   more...
 
Updated: Jun 3, 2011
 

Background

Human cryptosporidiosis is caused by infection with the Apicomplexa protozoans of the genus Cryptosporidium. Human illness was formerly thought to be caused by a single species, but molecular studies have demonstrated that several different species cause human cryptosporidiosis. Among the more common species are Cryptosporidium hominis, for which humans are the only natural host, and Cryptosporidium parvum, which infects bovines as well as humans.[1, 2] (See Etiology.)

Cryptosporidiosis mainly affects children. It causes a self-limited diarrheal illness in healthy individuals. Cryptosporidiosis is also recognized as a cause of persistent diarrhea in children and of severe, prolonged diarrhea in persons with acquired immunodeficiency syndrome (AIDS). The source of most endemic cryptosporidiosis cases is human-to-human fecal-oral transmission, but infection may also result from animal-to-person transmission and waterborne transmission. Major outbreaks resulting from waterborne transmission have been recorded.[3] (See Etiology, Epidemiology.)

Outbreaks of cryptosporidiosis should be detected by vigilant observation for increased case numbers at primary and public health care levels. (See Epidemiology.)

Also see Pediatric Cryptosporidiosis.

Next

Etiology

Cryptosporidium oocysts are highly infectious, requiring only 101 to 103 oocysts to cause human disease (50% infectious dose, 102). The oocysts are infectious immediately after excretion, and the life cycle of the parasite produces forms that reinvade the intestine. The location of the parasite in the intestine is intracellular but extracytoplasmic, which may contribute to the marked resistance of Cryptosporidium species to treatment. Large numbers of oocysts are excreted and are resistant to harsh conditions, including chlorine at levels usually applied in water treatment.

The mechanism by which Cryptosporidium causes diarrhea includes a combination of increased intestinal permeability, chloride secretion, and malabsorption, which are all thought to be caused by the host response to infection. In immunocompetent persons, the infection is usually limited to the small intestine. In persons with AIDS or certain congenital immunodeficiencies, the biliary tract may be involved.

Previous
Next

Epidemiology

Incidence in the United States

The frequency of cryptosporidiosis has not been well-defined. About 30% of the adult population of the United States is seropositive. The number of cases diagnosed has increased with improved diagnostic testing, with over 10,500 cases reported in 2008.[4] Still, most laboratories do not routinely test for this organism, and many laboratories use insensitive tests when testing for Cryptosporidium.[1] Studies have documented cryptosporidiosis in about 4% of stools sent for parasitologic examination.[5] More recently in studies using polymerase chain reaction (PCR) tests, Cryptosporidium species have been diagnosed in 6% of American travelers to Mexico.[6]

Prior to the availability of combination antiretroviral therapy, approximately 10-15% of patients with AIDS developed cryptosporidiosis over their lifetime. Like other opportunistic infections, the prevalence of cryptosporidiosis in AIDS patients has dropped dramatically.

International incidence

In developing countries, most people are infected as children. For example, studies in Brazil documented an infection rate of 90% for children under age 5 years who were living in slums. Serologic and stool studies have documented high rates of infection in Latin America, Africa, the Middle East, and South Asia. Overall, about 13% of stool studies submitted for parasitologic studies in developing countries reveal Cryptosporidium oocysts.

In persons with AIDS, the rate of cryptosporidiosis is higher in developing countries, ranging from 12-48% of persons with AIDS who have diarrhea.[1, 7]

Age predilection

The peak incidence of cryptosporidiosis is in children younger than 5 years. Infection is rare in immunocompetent adults in developing countries but can occur in persons with AIDS.

Previous
Next

Prognosis

Prolonged diarrhea (ie, >1 mo) and biliary disease indicate a poor prognosis in persons with AIDS.

Previous
Next

Complications

Sclerosing cholangitis, acalculous cholecystis, papillary stenosis, and pancreatitis may develop with biliary involvement.

Patients with AIDS may develop respiratory tract infections.

Rare cases of pancreatitis have been recorded in immunocompetent patients.

Cryptosporidiosis is an important cause of persistent diarrhea in developing countries. Children with persistent diarrhea develop worsening malnutrition, which may result in cognitive and fitness problems that persist for years.[8]

Chronic cryptosporidiosis may be complicated by biliary tract disease, malabsorption, and death in individuals with AIDS and malnourished children.[9]

Previous
Next

Patient Education

Encourage immunocompromised patients to consider using 1-μm water filters when drinking tap water.

Instruct patients to boil or filter water in countries with a high risk of transmission.

Instruct immunocompromised patients to avoid newborn animals (eg, calves, lambs), including domestic animals, and people with diarrhea. New pets for patients with AIDS should be older than 6 months and should not have diarrhea.

Instruct patients with AIDS, daycare workers, food handlers, and healthcare workers to avoid fecal-oral spread by wearing gloves and washing their hands after contact with human feces. Spread can occur after activities such as changing diapers.

Previous
 
 
Contributor Information and Disclosures
Author

Miguel M Cabada, MD  Fellow in Infectious Diseases, University of Texas Medical Branch School of Medicine

Miguel M Cabada, MD is a member of the following medical societies: Infectious Diseases Society of America, International Society for Infectious Diseases, and International Society of Travel Medicine

Disclosure: Nothing to disclose.

Coauthor(s)

A Clinton White Jr, MD  The Paul R Stalnaker, MD, Distinguished Professor of Internal Medicine, Director, Infectious Disease Division, Department of Internal Medicine, University of Texas Medical Branch School of Medicine

A Clinton White Jr, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Physicians, American Federation for Medical Research, American Society of Tropical Medicine and Hygiene, Christian Medical & Dental Society, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Specialty Editor Board

Jeffrey D Band, MD  Professor of Medicine, Oakland University William Beaumont School of Medicine; Director, Division of Infectious Diseases and International Medicine, Corporate Epidemiologist, William Beaumont Hospital; Clinical Professor of Medicine, Wayne State University School of Medicine

Disclosure: Nothing to disclose.

Francisco Talavera, PharmD, PhD  Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Medscape Salary Employment

Joseph F John Jr, MD, FACP, FIDSA, FSHEA  Clinical Professor of Medicine, Molecular Genetics and Microbiology, Medical University of South Carolina College of Medicine; Associate Chief of Staff for Education, Ralph H Johnson Veterans Affairs Medical Center

Disclosure: Nothing to disclose.

Chief Editor

Burke A Cunha, MD  Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital

Burke A Cunha, MD is a member of the following medical societies: American College of Chest Physicians, American College of Physicians, and Infectious Diseases Society of America

Disclosure: Nothing to disclose.

Acknowledgments

The authors and editors of Medscape Reference gratefully acknowledge the contributions of previous author Damon Eisen, MD, to the development and writing of the source article.

References
  1. White AC Jr. Cryptosporidiosis (Cryptosporidium hominis, Cryptosporidium parvum, other species). In: Mandell GL, Bennett JE, Dolin R, ed. Principles and Practice of Infectious Diseases. 6th ed. Philadelphia, PA: Elsevier Churchill Livingstone; 2005:3215-3228.

  2. Lima AAM, Samie A, Guerrant RL. Cryptosporidiosis. In: Guerrant RL, Walker DH, Weller PF, eds. Tropical Infectious Diseases. Philadelphia, Pa: Elsevier-Churchill Livingstone; 2011:640-63.

  3. Yoder JS, Beach MJ. Cryptosporidium surveillance and risk factors in the United States. Exp Parasitol. Jan 2010;124(1):31-9. [Medline].

  4. Yoder JS, Harral C, Beach MJ. Cryptosporidiosis surveillance - United States, 2006-2008. MMWR Surveill Summ. Jun 11 2010;59(6):1-14. [Medline].

  5. Amin OM. Seasonal prevalence of intestinal parasites in the United States during 2000. Am J Trop Med Hyg. Jun 2002;66(6):799-803. [Medline].

  6. Nair P, Mohamed JA, DuPont HL, et al. Epidemiology of cryptosporidiosis in North American travelers to Mexico. Am J Trop Med Hyg. Aug 2008;79(2):210-4. [Medline]. [Full Text].

  7. Wumba R, Longo-Mbenza B, Mandina M, et al. Intestinal parasites infections in hospitalized AIDS patients in Kinshasa, Democratic Republic of Congo. Parasite. Dec 2010;17(4):321-8. [Medline].

  8. Mondal D, Haque R, Sack RB, Kirkpatrick BD, Petri WA Jr. Attribution of malnutrition to cause-specific diarrheal illness: evidence from a prospective study of preschool children in Mirpur, Dhaka, Bangladesh. Am J Trop Med Hyg. May 2009;80(5):824-6. [Medline].

  9. Opintan JA, Newman MJ, Ayeh-Kumi PF, et al. Pediatric diarrhea in southern Ghana: etiology and association with intestinal inflammation and malnutrition. Am J Trop Med Hyg. Oct 2010;83(4):936-43. [Medline]. [Full Text].

  10. O'connor RM, Shaffie R, Kang G, Ward HD. Cryptosporidiosis in patients with HIV/AIDS. AIDS. Mar 13 2011;25(5):549-60. [Medline].

  11. Kaushik K, Khurana S, Wanchu A, Malla N. Evaluation of staining techniques, antigen detection and nested PCR for the diagnosis of cryptosporidiosis in HIV seropositive and seronegative patients. Acta Trop. Jul 2008;107(1):1-7. [Medline].

  12. Amadi B, Mwiya M, Musuku J, et al. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Lancet. Nov 2 2002;360(9343):1375-80. [Medline].

  13. Rossignol JF, Kabil SM, el-Gohary Y, Younis AM. Effect of nitazoxanide in diarrhea and enteritis caused by Cryptosporidium species. Clin Gastroenterol Hepatol. Mar 2006;4(3):320-4. [Medline].

  14. Rossignol JF, Ayoub A, Ayers MS. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. J Infect Dis. Jul 1 2001;184(1):103-6. [Medline].

  15. Kotler DP, Fogleman L, Tierney AR. Comparison of total parenteral nutrition and an oral, semielemental diet on body composition, physical function, and nutrition-related costs in patients with malabsorption due to acquired immunodeficiency syndrome. JPEN J Parenter Enteral Nutr. May-Jun 1998;22(3):120-6. [Medline].

  16. Lee MB, Greig JD. A review of gastrointestinal outbreaks in schools: effective infection control interventions. J Sch Health. Dec 2010;80(12):588-98. [Medline].

  17. Cabada MM, White AC Jr. Treatment of cryptosporidiosis: do we know what we think we know?. Curr Opin Infect Dis. Oct 2010;23(5):494-9. [Medline].

  18. Pantenburg B, White AC Jr. Nitazoxanide. In: Grayson ML, ed. Kucer's The Use of Antibiotics. 6th ed. London, United Kingdom: Hodder Arnold; 2010:2132-9.

Previous
Next
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.